|
|
Imunon Inc (NASDAQ: IMNN) |
|
*Market share is calculated based on total revenue.
Publicly Traded Peers of Imunon Inc
Moderna Inc
Share Performance
-74.24%
One Year
|
Moderna Inc
Profile
Moderna Inc's business model revolves around the development and commercialization of mRNA-based therapeutics and vaccines. They focus on using messenger RNA (mRNA) technology to create drugs that can help prevent and treat various diseases.
More about Moderna Inc 's Market Share
|
Novavax inc
Share Performance
-0.99%
This Quarter
|
Novavax inc
Profile
Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of novel vaccines. They aim to leverage their proprietary recombinant nanoparticle vaccine technology platform to address a wide range of infectious diseases. By collaborating with partners and conducting clinical trials, Novavax works towards bringing innovative vaccines to the global market.
More about Novavax inc 's Market Share
|
Gilead Sciences Inc
Share Performance
+1.91%
30 Days
|
Gilead Sciences Inc
Profile
Gilead Sciences Incs business model centers on researching, developing, and marketing innovative medicines, primarily targeting antiviral therapies. They focus on addressing unmet medical needs to enhance patient health globally.
More about Gilead Sciences Inc 's Market Share
|
Vaxart Inc
Share Performance
-38.78%
This Year
|
Vaxart Inc
Profile
Vaxart Inc's business model involves the development of oral vaccines through their proprietary tablet vaccine delivery platform.
More about Vaxart Inc 's Market Share
|
Curevac N v
Share Performance
+46.87%
One Year
|
Curevac N v
Profile
CureVac N.V. is a biopharmaceutical company focused on developing and manufacturing innovative mRNA-based therapeutics and vaccines. Their business model involves leveraging their proprietary technology platform to develop a diverse pipeline of potential mRNA-based products, from early-stage research to clinical trials. CureVac N.V. collaborates with partners and organizations to advance their product candidates, aiming to address unmet medical needs and improve patient outcomes.
More about Curevac N v 's Market Share
|
Biontech Se
Share Performance
-0.88%
Over The Past 5 Days
|
Biontech Se
Profile
Biontech SE's business model focuses on the development and commercialization of novel mRNA-based immunotherapies for various diseases, including cancer.
More about Biontech Se's Market Share
|
Inovio Pharmaceuticals Inc
Share Performance
-27.60%
This Quarter
|
Inovio Pharmaceuticals Inc
Profile
Inovio Pharmaceuticals Inc is a biotechnology company that focuses on the development and commercialization of immunotherapies for the treatment of various diseases, including cancers and infectious diseases. Their business model involves leveraging their proprietary platforms, such as DNA-based technology and electroporation, to design and develop novel vaccines and therapies which are then advanced through clinical trials and potential partnerships for further commercialization.
More about Inovio Pharmaceuticals Inc 's Market Share
|
Globestar Therapeutics Corporation
Share Performance
-77.78%
One Year
|
Globestar Therapeutics Corporation
Profile
Globestar Therapeutics Corporation's business model is focused on providing therapeutic solutions through innovative products and services aimed at improving healthcare outcomes.
More about Globestar Therapeutics Corporation's Market Share
|
Hoth Therapeutics Inc
Share Performance
+1.63%
30 Days
|
Hoth Therapeutics Inc
Profile
Hoth Therapeutics Inc's business model focuses on the development and commercialization of innovative therapies for dermatological disorders and other related conditions.
More about Hoth Therapeutics Inc's Market Share
|
Innovation Pharmaceuticals Inc
Share Performance
0.00%
One Year
|
Innovation Pharmaceuticals Inc
Profile
Innovation Pharmaceuticals Inc operates under a business model focused on pharmaceutical research and development. They strive to innovate and discover novel drug candidates to address unmet medical needs. Through collaborations, partnerships, and internal capabilities, they aim to bring potential therapies through clinical trials and eventually to market.
More about Innovation Pharmaceuticals Inc 's Market Share
|
Cocrystal Pharma Inc
Share Performance
-29.31%
This Year
|
Cocrystal Pharma Inc
Profile
Cocrystal Pharma Inc.'s business model focuses on the development of antiviral therapeutics to address unmet medical needs.
More about Cocrystal Pharma Inc 's Market Share
|
Oragenics Inc
Share Performance
-95.59%
One Year
|
Oragenics Inc
Profile
Oragenics Inc's business model revolves around developing and commercializing novel technologies and products to address unmet healthcare needs.
More about Oragenics Inc 's Market Share
|
Altimmune inc
Share Performance
-35.03%
One Year
|
Altimmune inc
Profile
Altimmune Inc's business model is focused on developing and commercializing innovative immunotherapies for treating infectious diseases and improving immune responses.
More about Altimmune inc 's Market Share
|
Oncternal Therapeutics Inc
Share Performance
-89.68%
One Year
|
Oncternal Therapeutics Inc
Profile
Oncternal Therapeutics Inc's business model focuses on developing and commercializing novel therapies for the treatment of cancer.
More about Oncternal Therapeutics Inc 's Market Share
|
Nanoviricides inc
Share Performance
+5.00%
Over The Past 5 Days
|
Nanoviricides inc
Profile
Nanoviricides Inc. is a pharmaceutical company that operates on a business model based on the development and commercialization of nanomedicines.
More about Nanoviricides inc 's Market Share
|
Shuttle Pharmaceuticals Holdings Inc
Share Performance
-3.30%
Over The Past 5 Days
|
Shuttle Pharmaceuticals Holdings Inc
Profile
Shuttle Pharmaceuticals Holdings Inc is a pharmaceutical company that operates on a business-to-business (B2B) model. They develop and manufacture a wide range of pharmaceutical products and then distribute them to other companies or medical institutions for further distribution or use. Their primary focus is on ensuring the quality and effectiveness of their products while partnering with other entities to ensure their widespread availability in the market.
More about Shuttle Pharmaceuticals Holdings Inc 's Market Share
|
Vaxxinity Inc
Share Performance
0.00%
30 Days
|
Vaxxinity Inc
Profile
Vaxxinity Inc is a company that operates on a business model that focuses on the development and distribution of vaccines.
More about Vaxxinity Inc 's Market Share
|
Vbi Vaccines Inc
Share Performance
-90.26%
This Year
|
Vbi Vaccines Inc
Profile
Vbi Vaccines Inc is a biopharmaceutical company that focuses on the development and commercialization of a new generation of vaccines and immunotherapies. Their business model revolves around leveraging their proprietary technologies to create innovative products that target a range of infectious diseases and immune-oncology indications. By conducting rigorous research and clinical trials, Vbi Vaccines aims to bring these novel therapies to market and address unmet medical needs.
More about Vbi Vaccines Inc's Market Share
|
Geovax Labs Inc
Share Performance
-13.12%
30 Days
|
Geovax Labs Inc
Profile
Geovax Labs Inc's business model primarily focuses on the development and commercialization of innovative vaccines to prevent and treat diseases, with a particular emphasis on HIV/AIDS. They aim to bridge the gap in preventing and managing these diseases through their vaccine candidates and strategic partnerships.
More about Geovax Labs Inc 's Market Share
|
Ayala Pharmaceuticals Inc
Share Performance
-19.80%
One Year
|
Ayala Pharmaceuticals Inc
Profile
Ayala Pharmaceuticals Inc is a biopharmaceutical company focused on developing targeted therapies for patients with rare and aggressive cancers. Their business model revolves around leveraging scientific expertise and strategic partnerships to advance their pipeline of potential treatments and ultimately bring them to market.
More about Ayala Pharmaceuticals Inc 's Market Share
|
Fortress Biotech Inc
Share Performance
+17.47%
This Quarter
|
Fortress Biotech Inc
Profile
Fortress Biotech Inc operates as a biopharmaceutical company that acquires, develops, and commercializes novel pharmaceutical and biotechnology products. Their business model focuses on partnering with academic institutions and biotech companies to advance preclinical and clinical-stage therapies for various diseases. Additionally, they aim to leverage their expertise and partnerships to improve the development process and bring innovative treatments to patients in need.
More about Fortress Biotech Inc 's Market Share
|
Acurx Pharmaceuticals inc
Share Performance
-25.31%
30 Days
|
Acurx Pharmaceuticals inc
Profile
Acurx Pharmaceuticals Inc. operates by developing and commercializing novel antibiotics to address the growing problem of bacterial antibiotic resistance. The company focuses on targeting serious and life-threatening infections caused by multi-drug-resistant bacterial strains. Acurx Pharmaceuticals aims to bring innovative solutions to market through research and development, strategic partnerships, and a strong emphasis on improving patient outcomes.
More about Acurx Pharmaceuticals inc 's Market Share
|
Arcus Biosciences Inc
Share Performance
-39.52%
This Year
|
Arcus Biosciences Inc
Profile
Arcus Biosciences Inc is a biotechnology company that focuses on developing immuno-oncology therapies. Their business model revolves around discovering and developing novel small molecule and antibody therapeutics to target various cancer indications. They aim to combine their extensive understanding of the immune system with innovative technology platforms to create effective treatments for patients with cancer.
More about Arcus Biosciences Inc 's Market Share
|
Fibrogen Inc
Share Performance
+41.67%
30 Days
|
Fibrogen Inc
Profile
Fibrogen Inc's business model focuses on the development and commercialization of innovative therapeutics for unmet medical needs. They aim to discover and create treatments by leveraging their expertise in fibrosis and tissue regeneration. Fibrogen Inc collaborates with strategic partners and utilizes its extensive research and development capabilities to bring these therapies to market and improve the lives of patients.
More about Fibrogen Inc 's Market Share
|
Alpine Immune Sciences Inc
Share Performance
+0.03%
Over The Past 5 Days
|
Alpine Immune Sciences Inc
Profile
Alpine Immune Sciences Inc is a biotechnology company focused on developing immunotherapies to treat cancer and autoimmune diseases. Their business model involves identifying unique protein targets and using their proprietary technology platform to engineer and develop novel therapeutic antibodies that modulate the immune system. They aim to partner with pharmaceutical companies for the clinical development and commercialization of their product candidates.
More about Alpine Immune Sciences Inc 's Market Share
|
Contrafect Corporation
Share Performance
-80.77%
30 Days
|
Contrafect Corporation
Profile
ContraFect Corporation is a biotechnology company that focuses on the development of protein and antibody-based therapies to treat drug-resistant infectious diseases.
More about Contrafect Corporation's Market Share
|
Moonlake Immunotherapeutics
Share Performance
-0.90%
This Year
|
Moonlake Immunotherapeutics
Profile
Moonlake Immunotherapeutics's business model revolves around the development and commercialization of innovative immunotherapies for the treatment of diseases.
More about Moonlake Immunotherapeutics's Market Share
|
Lianbio
Share Performance
-92.70%
This Year
|
Lianbio
Profile
LianBio is a biopharmaceutical company that focuses on accelerating the development and commercialization of innovative medicines in the Chinese market. They collaborate with global partners to identify and acquire promising drug candidates, providing them with regulatory expertise and commercialization capabilities. By leveraging their deep understanding of the Chinese healthcare landscape, LianBio aims to bridge the gap between global innovation and Chinese patient needs.
More about Lianbio's Market Share
|
Matinas Biopharma Holdings Inc
Share Performance
-4.00%
Over The Past 5 Days
|
Matinas Biopharma Holdings Inc
Profile
Matinas Biopharma Holdings Inc operates as a clinical-stage biopharmaceutical company. Their business model centers around developing therapeutics through the utilization of lipid nano-crystal (LNC) platform technologies. These technologies enable the effective delivery of drugs to improve patient outcomes in various diseases and conditions such as fungal infections, viral infections, and cancer.
More about Matinas Biopharma Holdings Inc 's Market Share
|
Dynavax Technologies Corporation
Share Performance
+4.59%
One Year
|
Dynavax Technologies Corporation
Profile
Dynavax Technologies Corp operates through a business model focused on the development and commercialization of innovative vaccines. The company aims to leverage its expertise in immunology to create novel products that address unmet medical needs. Dynavax utilizes strategic collaborations and partnerships to advance its vaccine candidates and bring them to market efficiently.
More about Dynavax Technologies Corporation's Market Share
|
Opko Health Inc
Share Performance
-7.59%
This Year
|
Opko Health Inc
Profile
Opko Health Inc is a biotechnology and pharmaceutical company that operates through various business segments. The company primarily focuses on diagnostics, developing and commercializing novel diagnostic tests for various conditions. Additionally, Opko Health engages in the production and sale of pharmaceuticals and vaccines, as well as the research and development of new medical technologies.
More about Opko Health Inc 's Market Share
|
Emergent Biosolutions Inc
Share Performance
-32.52%
This Year
|
Emergent Biosolutions Inc
Profile
Emergent Biosolutions Inc's business model focuses on developing and manufacturing specialty products for the prevention and treatment of public health threats.
More about Emergent Biosolutions Inc 's Market Share
|
Organon and Co
Share Performance
-3.57%
Over The Past 5 Days
|
Organon and Co
Profile
Organon and Co's business model revolves around developing and manufacturing pharmaceutical products.
More about Organon and Co 's Market Share
|
Regeneron Pharmaceuticals Inc
Share Performance
-9.56%
This Quarter
|
Regeneron Pharmaceuticals Inc
Profile
Regeneron Pharmaceuticals Inc operates a business model centered on the discovery and commercialization of cutting-edge biopharmaceuticals, particularly in the fields of ophthalmology, oncology, immunology, and rare diseases. They leverage their strong research and development capabilities, including their proprietary technologies, to create innovative therapies that address unmet medical needs. Additionally, Regeneron forms strategic collaborations and partnerships to enhance their development pipeline and expand market access for their products.
More about Regeneron Pharmaceuticals Inc 's Market Share
|
Astrazeneca Plc
Share Performance
-2.62%
30 Days
|
Astrazeneca Plc
Profile
AstraZeneca Plc is a global biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. Their business model involves investing extensively in research and development to discover novel treatments for a wide range of diseases. AstraZeneca then markets and sells these medicines globally, collaborating with healthcare providers and leveraging their strong sales and distribution networks.
More about Astrazeneca Plc's Market Share
|
Sanofi
Share Performance
-9.75%
This Quarter
|
Sanofi
Profile
Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs.
More about Sanofi's Market Share
|
Novartis Ag
Share Performance
-2.78%
30 Days
|
Novartis Ag
Profile
Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products.
More about Novartis Ag's Market Share
|
Dmk Pharmaceuticals Corporation
Share Performance
-65.61%
This Year
|
Dmk Pharmaceuticals Corporation
Profile
DMK Pharmaceuticals Corporation has a business model focused on the development, manufacturing, and distribution of pharmaceutical products.
More about Dmk Pharmaceuticals Corporation's Market Share
|
Innovation1 Biotech Inc
Share Performance
0.00%
30 Days
|
Innovation1 Biotech Inc
Profile
The business model of Innovation1 Biotech Inc involves developing and commercializing innovative biotechnological products and solutions for various industries. The company focuses on research, development, and manufacturing, aiming to provide cutting-edge biotech solutions that meet the needs of diverse markets.
More about Innovation1 Biotech Inc 's Market Share
|
Actavia Life Sciences Inc
Share Performance
0.00%
This Quarter
|
Actavia Life Sciences Inc
Profile
Rasna Therapeutics Inc is a biotechnology company that focuses on developing innovative therapies for the treatment of cancer and other diseases. Their business model revolves around leveraging cutting-edge research and technology to discover and develop novel drug candidates. They aim to partner with pharmaceutical companies or license their intellectual property to bring their therapies to market and ultimately improve patient outcomes.
More about Actavia Life Sciences Inc 's Market Share
|
180 Life Sciences Corp
Share Performance
+117.34%
30 Days
|
180 Life Sciences Corp
Profile
180 Life Sciences Corp is a biotechnology company engaged in the research and development of novel drugs that target inflammation and fibrosis to address various diseases such as fibrosis, inflammation, and pain.
More about 180 Life Sciences Corp's Market Share
|
Tiziana Life Sciences Ltd
Share Performance
+4.05%
Over The Past 5 Days
|
Tiziana Life Sciences Ltd
Profile
Tiziana Life Sciences Ltd's business model focuses on the development and commercialization of innovative therapeutics in the field of immunology and oncology.
More about Tiziana Life Sciences Ltd's Market Share
|
Viracta Therapeutics Inc
Share Performance
-38.75%
This Quarter
|
Viracta Therapeutics Inc
Profile
Viracta Therapeutics Inc is a biopharmaceutical company focused on developing targeted therapies for viral-associated cancers. The company aims to advance research, develop innovative treatments, and commercialize products to improve the lives of patients suffering from these types of cancers.
More about Viracta Therapeutics Inc 's Market Share
|
Hcw Biologics Inc
Share Performance
+4.17%
Over The Past 5 Days
|
Hcw Biologics Inc
Profile
HCW Biologics Inc is a biotechnology company that operates on a business model focused on the research, development, and commercialization of biologic therapies. The company primarily focuses on developing and manufacturing novel biological products for various medical conditions. Their business model involves collaboration with industry partners, conducting clinical trials, and securing regulatory approvals for the commercialization of their biologic therapies.
More about Hcw Biologics Inc 's Market Share
|
Renovorx Inc
Share Performance
-7.80%
30 Days
|
Renovorx Inc
Profile
Renovorx Inc is a medical technology company specializing in the development of innovative treatments for cardiovascular diseases. Their business model focuses on creating and commercializing minimally invasive therapies for patients suffering from conditions like myocardial infarction and heart failure. By leveraging cutting-edge medical devices and procedures, Renovorx aims to provide effective and efficient treatments that can significantly improve patient outcomes and quality of life.
More about Renovorx Inc 's Market Share
|
Indaptus Therapeutics Inc
Share Performance
-80.55%
One Year
|
Indaptus Therapeutics Inc
Profile
Indaptus Therapeutics Inc's business model focuses on developing and commercializing innovative therapies in the healthcare industry.
More about Indaptus Therapeutics Inc 's Market Share
|
Iterum Therapeutics Plc
Share Performance
-9.00%
Over The Past 5 Days
|
Iterum Therapeutics Plc
Profile
Iterum Therapeutics Plc is a pharmaceutical company that focuses on the research, development, and commercialization of innovative anti-infectives for the treatment of serious and life-threatening infections. They aim to address unmet medical needs in this space by advancing their product candidates through clinical trials and ultimately bringing them to market.
More about Iterum Therapeutics Plc's Market Share
|
Esperion Therapeutics Inc
Share Performance
+12.50%
30 Days
|
Esperion Therapeutics Inc
Profile
Esperion Therapeutics Inc's business model focuses on the development and commercialization of innovative therapies for addressing cardiovascular diseases.
More about Esperion Therapeutics Inc 's Market Share
|
Palatin Technologies Inc
Share Performance
-89.13%
This Quarter
|
Palatin Technologies Inc
Profile
Palatin Technologies Inc has a business model focused on developing and commercializing innovative medicines in the field of reproductive healthcare and sexual dysfunction. The company's revenue streams primarily come from partnerships, licensing agreements, and product sales.
More about Palatin Technologies Inc 's Market Share
|
Altamira Therapeutics Ltd
Share Performance
-27.11%
30 Days
|
Altamira Therapeutics Ltd
Profile
Altamira Therapeutics Ltd's business model revolves around developing and commercializing innovative therapeutics.
More about Altamira Therapeutics Ltd 's Market Share
|
Leap Therapeutics Inc
Share Performance
+10.03%
30 Days
|
Leap Therapeutics Inc
Profile
Leap Therapeutics Inc. is a biopharmaceutical company with a business model focused on discovering and developing targeted therapies for cancer. They aim to leverage their expertise in identifying novel targets and developing antibody-based therapies to address unmet medical needs in oncology. By advancing their pipeline of innovative drugs, they seek to provide effective treatment options for patients and create value for stakeholders in the pharmaceutical industry.
More about Leap Therapeutics Inc 's Market Share
|
Cellectar Biosciences Inc
Share Performance
-46.84%
This Quarter
|
Cellectar Biosciences Inc
Profile
Cellectar Biosciences Inc is a biopharmaceutical company that focuses on the development of targeted cancer therapies. They utilize their proprietary drug conjugation platform to create targeted small molecules that can selectively bind and deliver radioactive isotopes directly to cancer cells. Their business model revolves around developing and commercializing these innovative therapies for the treatment of various types of cancer, aiming to improve patient outcomes and potentially revolutionize cancer treatment.
More about Cellectar Biosciences Inc 's Market Share
|
Xenetic Biosciences Inc
Share Performance
-7.16%
This Year
|
Xenetic Biosciences Inc
Profile
Xenetic Biosciences Inc is a biopharmaceutical company that focuses on developing personalized therapeutics with the potential to improve patient outcomes. The company employs a business model centered around leveraging its proprietary drug development platform to partner with pharmaceutical companies and advance novel drug candidates through preclinical and clinical stages.
More about Xenetic Biosciences Inc 's Market Share
|
Xbiotech Inc
Share Performance
-28.54%
This Year
|
Xbiotech Inc
Profile
Xbiotech Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic antibodies. They seek to address unmet medical needs by leveraging their proprietary True Human antibody technology.
More about Xbiotech Inc 's Market Share
|
Journey Medical Corp
Share Performance
+79.75%
This Year
|
Journey Medical Corp
Profile
Journey Medical Corporation is a pharmaceutical and medical device company that specializes in developing and commercializing innovative products for dermatology and aesthetics. Their business model revolves around conducting research and development to create new products, acquiring the necessary regulatory approvals, and partnering with healthcare professionals to effectively distribute and market these products. By focusing on dermatology and aesthetics, Journey Medical Corporation aims to address unmet medical needs and provide cutting-edge solutions to improve patient outcomes in these fields.
More about Journey Medical Corp's Market Share
|
Casi Pharmaceuticals inc
Share Performance
-11.89%
Over The Past 5 Days
|
Casi Pharmaceuticals inc
Profile
Casi Pharmaceuticals Inc. operates under a business model that focuses on the development and commercialization of innovative pharmaceutical products. They likely employ a combination of in-house research and development, partnerships, and licensing agreements to bring their products to market. The company may also engage in strategic marketing and distribution partnerships to ensure the successful commercialization of their therapeutics.
More about Casi Pharmaceuticals inc 's Market Share
|
Mineralys Therapeutics Inc
Share Performance
+16.33%
This Year
|
Mineralys Therapeutics Inc
Profile
Mineralys Therapeutics Inc is a biotechnology company that follows the business model of developing and commercializing novel therapeutics for various diseases. They focus on discovering and advancing small molecule drugs based on innovative research approaches. Their business model is centered around conducting preclinical and clinical trials, obtaining regulatory approvals, and ultimately bringing their therapeutic products to market for improved patient outcomes.
More about Mineralys Therapeutics Inc 's Market Share
|
Third Harmonic Bio Inc
Share Performance
0.00%
Over The Past 5 Days
|
Third Harmonic Bio Inc
Profile
Third Harmonic Bio Inc's business model centers around developing and commercializing innovative therapeutic solutions through the utilization of bioinformatics and genomics.
More about Third Harmonic Bio Inc 's Market Share
|
Immunome Inc
Share Performance
+24.18%
This Quarter
|
Immunome Inc
Profile
Immunome Inc is a biotechnology company that focuses on developing novel immunotherapies. Their business model revolves around leveraging their proprietary discovery engine to identify therapeutic antibodies for infectious diseases and cancer. By collaborating with partners and through their own clinical development efforts, they aim to bring these promising treatments to the market.
More about Immunome Inc's Market Share
|
Takeda Pharmaceutical Company Limited
Share Performance
-1.97%
30 Days
|
Takeda Pharmaceutical Company Limited
Profile
Takeda Pharmaceutical Company Limited operates under a business model that primarily focuses on research, development, and commercialization of innovative pharmaceutical products. They collaborate with various stakeholders across the healthcare industry, including academia, biotechnology companies, and patient advocacy groups, to drive scientific advancements and understand patient needs. By leveraging their expertise, global presence, and strategic partnerships, Takeda aims to make a positive impact on patients' lives while ensuring long-term growth and sustainability.
More about Takeda Pharmaceutical Company Limited's Market Share
|
An2 Therapeutics Inc
Share Performance
-20.86%
This Year
|
An2 Therapeutics Inc
Profile
An2 Therapeutics Inc is a biotechnology company that develops therapeutics for the treatment of rare diseases. Their business model focuses on research and development of innovative drugs that target specific genetic mutations responsible for these rare conditions, aiming to provide effective and personalized treatments. By collaborating with pharmaceutical partners and leveraging their expertise in drug discovery, An2 Therapeutics Inc aims to bring their therapies to market and improve the lives of patients with rare diseases.
More about An2 Therapeutics Inc 's Market Share
|
Structure Therapeutics Inc
Share Performance
-12.90%
30 Days
|
Structure Therapeutics Inc
Profile
Structure Therapeutics Inc is a biotechnology company that utilizes a structure-based approach to develop innovative therapeutics. They focus on identifying and targeting unique protein structures to create novel drugs for various diseases.
More about Structure Therapeutics Inc 's Market Share
|
Mirati Therapeutics Inc
Share Performance
+3.77%
This Quarter
|
Mirati Therapeutics Inc
Profile
Mirati Therapeutics Inc is a biotechnology company that focuses on the research, discovery, and development of precision oncology treatments for patients with cancer. Their business model involves leveraging their proprietary drug discovery platform to identify and develop targeted therapies, and collaborating with partners for the commercialization of their products.
More about Mirati Therapeutics Inc 's Market Share
|
Prometheus Biosciences Inc
Share Performance
+66.60%
This Quarter
|
Prometheus Biosciences Inc
Profile
Prometheus Biosciences Inc is a biotechnology company that operates on a subscription-based business model. Their platform offers personalized diagnostic tools and services to healthcare providers, enabling them to deliver targeted treatments for patients with gastrointestinal diseases. By providing ongoing support and monitoring, Prometheus aims to improve patient outcomes and revolutionize the management of chronic conditions in the field of gastroenterology.
More about Prometheus Biosciences Inc 's Market Share
|
Eli Lilly And Company
Share Performance
-0.82%
This Year
|
Eli Lilly And Company
Profile
Eli Lilly and Company operates as a global pharmaceutical firm that focuses on developing innovative medicines in areas such as diabetes, oncology, and neurodegeneration. Their business model emphasizes research and development, strategic partnerships, and a strong commitment to improving patient outcomes through advanced therapeutics.
More about Eli Lilly And Company's Market Share
|
Johnson and Johnson
Share Performance
+8.18%
30 Days
|
Johnson and Johnson
Profile
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
More about Johnson and Johnson's Market Share
|
Merck and Co Inc
Share Performance
-0.25%
30 Days
|
Merck and Co Inc
Profile
Merck & Co. Inc. operates primarily as a research-driven pharmaceutical company, focused on the development, manufacturing, and marketing of prescription drugs and vaccines globally. It aims to address unmet medical needs through innovative research, collaborations, and rigorous clinical trials, while promoting patient well-being and contributing to global healthcare with high-quality, affordable medications.
More about Merck and Co Inc 's Market Share
|
Bristol myers Squibb Company
Share Performance
-16.61%
This Year
|
Bristol myers Squibb Company
Profile
Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes.
More about Bristol myers Squibb Company's Market Share
|
Pfizer Inc
Share Performance
+1.83%
30 Days
|
Pfizer Inc
Profile
Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.
More about Pfizer Inc's Market Share
|
Vir Biotechnology Inc
Share Performance
-46.06%
One Year
|
Vir Biotechnology Inc
Profile
Vir Biotechnology Inc is a clinical-stage immunology company that focuses on developing and commercializing innovative treatments for infectious diseases. Their business model revolves around the discovery and development of antibody therapies and other immunological approaches to combat a wide range of viral pathogens. They collaborate with leading research institutions and pharmaceutical companies to accelerate the development and commercialization of their products.
More about Vir Biotechnology Inc 's Market Share
|
Nektar Therapeutics
Share Performance
+2.17%
Over The Past 5 Days
|
Nektar Therapeutics
Profile
Nektar Therapeutics operates under a business model focused on developing and commercializing innovative medicines. The company's approach involves utilizing its proprietary technology platforms to create novel therapeutic candidates and establish partnerships with pharmaceutical and biotechnology firms for clinical development and commercialization. Nektar Therapeutics aims to bring transformative therapies to market that address significant unmet medical needs.
More about Nektar Therapeutics's Market Share
|
Sources: Imunon Inc and all companies mentioned above in this report
|
